We are not alone. When we look around the earth, we see a vast array of different kinds of organisms. Besides visible plants and animals, there is an even more vast world of microscopic bacteria, single celled organisms, and viruses that are essential to all forms of life, on every part of the planet. Every human being is colonized with as many non-human microorganisms as human cells.
Cybele Microbiome's proprietary platform creates natural products in 16X less time than conventional manufacturing, inducing
Nicole’s mission is to make products that make a meaningful difference in people’s health. For a long-time she thought this meant understanding human genetics to find drug targets—but after discovering the incredible impact and potential of the microbiome, her work pivoted to methods, modeling, and ultimately commercializing microbiome technologies that could help people’s health and wellness, and prevent disease in the consumer space. She co-founded Cybele Microbiome out of her over 19 years of experience in population and statistical genetics, the microbiome, and the metagenome. She trained at the University of Michigan and University of Chicago and is an expert in the microbiome and metagenome having worked with Drs. Rob Knight and Jack Gilbert. She was the first employee of the Rob Knight’s startup Biota Technology. She is cited >2000 times, is an active member of an NSF microbiome-related grant review committee, a member of the NIAID PPC/TTP workshop for skin applied insect repellents, as well as an invited speaker in the microbiome and metagenome space.
Eddie has over 20 years of experience in commercializing technologies and product development and launches in biotechnology. Eddie received his Ph.D., in Biological Chemistry from MIT and completed a post-doc at Harvard. He has expertise in microbiome sample preparation and multiple patents and products in this space. At MO BIO Laboratories his team commercialized what became the gold-standard kits for DNA and RNA extraction for microbiome samples, ultimately contributing to the acquisition of MO BIO by Qiagen. He also previously worked at the Quantum Dot Corporation, NanoMR (acquired by DNAe), and currently is the VP of R&D at Active Motif.
Steve is a biochemist with expertise in the microbiome and microbiology. Steve trained at UCSD and Scripps, mastering *both* the wet and also dry-lab.
James is a microbiologist who trained with Drs. David Low and Chris Hayes at UC Santa Barbara. Prior to this he earned a masters at UMass and a bachelors at Tufts. James is a serious amateur climber and can be found hiking, camping, and climbing the plethora of spots in SoCal when not tooling in the lab.
Larry Allgaier former CEO of Novartis OTC and president of Mars-Purina, CEO New Chapter (acquired by P&G), current Partner JAB Holding Company
Graham Rigby, [Acting CMO] MBA current CIO of Care/Of a vitamin/supplement company, former CIO of Organic India and former CIO of New Chapter (acquired by P&G), launched countless products in the consumer and direct to consumer space; Board of Trustee member and Chair of the American Herbal Products Association
Craig Elbert current CEO of Care/Of, former Head of marketing at Bonobos (exited to Walmart)
Dr. Vik Rao Executive Director of Research Triangle Energy Institute, former CTO Halliburton
Damien Perriman MBA SVP business development specialty products at Genomatica, former Dow Chemicals and Verdezyne
Dr. Rob Knight expert in the microbiome and current CSO Biota Technologies Inc., current Director of the Center for Microbiome Innovation and Professor of Pediatrics and Computer Science & Engineering at UCSD, Fellow of the American Association for the Advancement of Science and of the American Academy of Microbiology, author of “Follow Your Gut: The Enormous Impact of Tiny Microbes”, coauthor of “Dirt is Good: The Advantage of Germs for Your Child’s Developing Immune System, and spoke at TED in 2014, created gold-standard microbiome bioinformatics pipelines QIME, QIITA, and QIIME2 and standard methods of analysis such as UniFrac
Dr. Pieter Dorrenstein expert in chemioinformatics and metabolomics. Cited over 20k times. Created and maintains GNPS database. Profiled in Nature, CNBC, NY Times, Washington Post, and CNN. Current UCSD Professor-Skaggs School of Pharmacy; Director Collaborative Mass Spectrometry Innovation Center; Co-Director, Institute for Metabolomics Medicine.
Dr. Janet Warrington current SVP Centrillion Biosciences, founder at Second Genome (a microbiome company), created the first FDA approved genetic array technology
Dr. Jeff Lievense Senior Advisor to CEO at Genomatica, former Amyris VP, expert in genetic engineering
Dr. Justin Kuczynski Google Senior Developer, Microbiome expert and data scientist, former senior scientist at Second Genome, wrote gold-standard microbiome processing software QIIME, PhD with Rob Knight